| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7504573 | Drug and Alcohol Dependence | 2015 | 11 Pages |
Abstract
Memantine 30Â mg significantly improved short-term treatment with buprenorphine/naloxone for opioid dependent young adults by reducing relapse and opioid use after buprenorphine discontinuation. Combined short-term treatment with buprenorphine/naloxone may be an effective alternative treatment to long-term methadone or buprenorphine maintenance in young adults.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Gerardo Gonzalez, Gregory DiGirolamo, Mauricio Romero-Gonzalez, David Smelson, Douglas Ziedonis, Monika Kolodziej,